Fathom Therapeutics
Last verified 2026-05-21. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $65.0Mattributed |
|---|---|
| Latest round | series-a, $47.0M, 2026-04-27attributed |
| Founded | 2019 |
| Headquarters | Boston, US |
| Industry | bio |
| Stage | series-a |
| Website | fathomtherapeutics.com |
Fathom Therapeutics uses physics-based simulation and AI to model protein motion at atomic resolution. It serves internal programs and pharma partners pursuing undruggable targets. Its Microcosmos platform speeds protein-dynamics modeling up to 10,000 times for more precise molecules.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-27 | series-a | $47.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $47.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $65.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | fathomtherapeutics.com, read 2026-05-21 |
| Description | self-reported | fathomtherapeutics.com, read 2026-05-21 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.